May 7, 2018 / 8:20 AM / 6 months ago

BRIEF-Suven Life Sciences Says U.S. FDA Issued EIR For Co's Facility At Pashamylaram

May 7 (Reuters) - Suven Life Sciences Ltd:

* SAYS SUVEN’S PASHAMYLARAM’S UNIT SUCCESSFULLY COMPLETES US FDA INSPECTION

* FDA DETERMINED THAT THE INSPECTION CLASSIFICATION OF THIS FACILITY IS “NO ACTION INDICATED

* BASED ON INSPECTION, FACILITY CONSIDERED TO BE IN ACCEPTABLE STATE OF COMPLIANCE W.R.T. CURRENT GOOD MANUFACTURING PROCESSES

* FDA ISSUED ESTABLISHMENT INSPECTION REPORT FOR SUVEN FACILITY AT PASHAMYLARAM Source text - bit.ly/2KFOLJP Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below